Epilepsy Blog Relay: Sarah Louise shares her experience with uncontrolled seizures

by Jessica K. Smith | 0

fff3ec_9f942a3b9a5245e88da162d36ec75a03~mv2 – Living Well With Epilepsy — March 4

This post is part of the Epilepsy Blog Relay™ which will run from March 1 to March 31, 2018. Follow along!

Day 4 of the Epilepsy Blog Relay™

Sarah Louise joins the Epilepsy Blog Relay with an update from her site, Miss Sarah Louise’s Masterpieces and Munchies. She shares her experiences with epilepsy, as well as tips on living with food allergies.

As of February 28, Sarah Louise was back in the hospital again. Sarah Louise writes, “The whole month of February my seizures have been off the charts more so than during the past 6 months.

Read Sarah Louise’s Post

NEXT UP: Watch for Jewel’s story on liveoutloud4epilepsy.org. For the full schedule of bloggers participating in the Epilepsy Blog Relay™ visit livingwellwithepilepsy.com.

TWITTER CHAT: And don’t miss your chance to connect with bloggers on the #LivingWellChat on April 2 at 7PM ET.

Jessica K. Smith Founder and CEO; Executive Director

Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

See Full Bio